Autopsy report · NCT00079846
Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy
Cause of deathNo reason given
Life of this trial
- Registered 6 months after it had already started.
- Ran for about 1 year 7 months before it stopped.
- 60 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Medical Research Laboratories International
- Sponsor type
- Industry
- Conditions
- Familial Hypercholesterolemia
- Interventions
- Implitapide
- Participants
- 60
- Sites
- 6
- Countries
- Canada, Israel, Netherlands, Norway, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.